WeVote
Log In

Bill

Bill

H 779

An Act to protect 340B providers in the MassHealth program

194th Legislature (2025-2026) Introduced by Vanna Howard and 3 co-sponsors

Massachusetts bill protecting 340B drug discount program access for MassHealth providers to maintain pharmaceutical affordability for low-income patients.

Reporting date extended to Friday, July 31, 2026
0
WeVote Research Nonpartisan
Bill Summary · H 779

Legislative bill overview

H 779 aims to protect 340B drug discount program providers participating in Massachusetts's MassHealth program. The bill appears designed to safeguard these healthcare organizations' ability to access discounted pharmaceuticals under the federal 340B program while serving low-income and uninsured patients through MassHealth.

Why is this important

The 340B program provides significant drug cost savings to safety-net hospitals, community health centers, and other providers serving vulnerable populations. Protections for these providers directly impact their financial sustainability and capacity to serve MassHealth beneficiaries, potentially affecting healthcare access and affordability for hundreds of thousands of low-income Massachusetts residents.

Potential points of contention

  • Pharmaceutical industry opposition: Drug manufacturers may resist provisions that limit their ability to restrict 340B discounts or impose additional conditions on participating providers
  • Scope ambiguity: The bill's exact protections remain unclear from available information; stakeholders may disagree on what constitutes adequate "protection" versus overreach
  • Budget implications: Expanded 340B protections could affect state pharmaceutical spending projections and MassHealth program costs, raising fiscal concerns among lawmakers

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.